Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS (Details Narrative)

v3.22.1
ACQUISITIONS (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended
Jun. 01, 2021
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Dec. 31, 2021
Business Acquisition [Line Items]          
Weighted average amortization period   3 years      
Revenue   $ 35,341   $ 29,768  
Difference between, actual revenue and proforma revenue   35,341   39,455  
Med SR [Member]          
Business Acquisition [Line Items]          
Earnout, payment $ 13,000        
Fair value of contingent consideration 5,600 2,500     $ 3,100
Consideration paid 1,500        
Revenue and backlog milestones, payments $ 500        
Additional shares held, terms 18 months        
Escrow, settlement     $ 250    
Working capital, adjustment     $ 250    
Escrow, deposit   71      
Consideration paid   $ 1,000      
Cash         $ 12,300
Weighted average amortization period   3 years      
Revenue   $ 7,300      
Difference between, actual revenue and proforma revenue       $ 9,700  
Asset and Stock Purchase Agreement [Member] | MedMatica [Member]          
Business Acquisition [Line Items]          
Consideration paid $ 10,000        
Working capital deficiency 3,800        
Maximum earn-out payments based upon acheivements 8,000        
Additional maximum earn-out payments based upon acheivements $ 5,000